Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients

BACKGROUND: Limited data exist regarding mucosal healing (MH) and therapeutic drug monitoring (TDM) in pediatric Crohn's disease (CD) patients treated with adalimumab (ADL). We aimed to investigate the associations between ADL trough levels (TLs) and MH, and between ADL TLs and histologic remis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Korean Med Sci
Prif Awduron: Choi, So Yoon, Choi, Young Ok, Choe, Yon Ho, Kang, Ben
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Academy of Medical Sciences 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183843/
https://ncbi.nlm.nih.gov/pubmed/32329259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e114
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg